The University of Texas College of Pharmacy welcomes you to the 2016 Psychiatric Pharmacotherapy Update CE event, in Austin, Texas on October 27-28. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.
Hotel Reservations: See Location website here for more information
Date: Oct 27, 2016 07:45 AM - Oct 28, 2016 04:00 PM
Registration closes on Oct 28, 2016 09:00 AM
“This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
|
|
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
|
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit. In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, return their completed Record of Attendance Form at the conclusion of the program, and return to this website to complete the online evaluation. |
Jason E. Schillerstrom, MD
|
Collin Hovinga, Pharm.D., M.S., FCCP
Disclosure : Dr. Hovinga has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
Keith S. Garcia, MD, PhD
Disclosure : Dr. Garcia has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
Kimberly Arlinghaus, MD
Disclosure : Dr. Arlinghaus has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
Nile J. Barnes. Pharm.D.
Disclosure : Dr. Barnes is a Team Leader for the UT Austin program Operation Naloxine.org – which solicits and receives donations from Kaleo and Adapt for the Texas Overdose Naloxine Initiative (TONI). |
Ali Abbas Asghar-Ali, M.D.
Brief Bio : Associate Director for Education, South Central MIRECC Director of Geriatric Psychiatry Fellowship Associate Professor, Baylor College of Medicine Geriatric Psychiatrist, Michael E. DeBakey VA Medical Center Disclosure : Dr. Ali Abbas Asghar-Ali has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
Stephen R. Saklad, PharmD, BCPP, Pharm.D., BCPP
Disclosure : Financial Disclosure: consultant or advisory role with Eli Lilly and Ortho McNeil Janssen; on the speaker’s bureau for Janssen, Merck, and Novartis; investigator Ortho McNeil Janssen |
Michael O’Neil, Pharm.D.
Disclosure : Dr. O’Neil has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
R. Lowell McRoberts, M.D.
Disclosure : Dr. McRoberts has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
Stephen Strakowski, M.D.
Disclosure : Dr. Starkowski has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Consultant: Chair of DSMB’s for Sunovion, human resources consultant for Procter & Gamble |
Carlos Tirado, M.D., M.P.H., F.A.B.A.M
Disclosure : Dr. Tirado has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Speakers Bureau: Indivior & Alkermes Consultant: US WorldMeds as a Medical Monitor |
Ruth Ann Luna, Ph.D., MB(ASCP)CM
Disclosure : Dr. Luna has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
John M. Oldham, M.D., M.S.
Disclosure : Dr. Oldham has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose. |
Troy Moore PharmD, MS Pharm, BCPP
Disclosure : Financial Disclosure: no relevant financial relationships to disclose |